Skip to main content

View full-text article in PMC

. 2022 Feb 28;20(1):91–99. doi: 10.2174/1570162X20666211227154558

Table 3.

Incidence of oral lesions.

Oral Manifestations	Patients on HAART				Treatment-naive Patients (n = 114) n (%)
Oral Manifestations	6 months (N = 42) n (%)	12 months (N = 45) n (%)	18 months (N = 45) n (%)	Overall (n = 132) n (%)	Treatment-naive Patients (n = 114) n (%)
Periodontitis	25 (59.52)	19 (42.22)	21 (46.66)	64 (48.5 %)	51 (44.7 %)
Gingivitis	12 (28.57)	18 (40)	19 (42.22)	49 (37.1 %)	14 (12.3 %)
Oral candidiasis	3 (7.14)	3 (6.66)	3 (6.66)	9 (6.8 %)	5 (4.4 %)
Aphthous ulcer	1 (2.38)	-	-	1 (0.8 %)	1 (0.9 %)
Hairy leukoplakia	2 (4.76)	3(6.66	2 (4.44)	7 (5.3 %)	18 (15.8 %)

HAART: Highly active antiretroviral therapy.